Becton Dickinson & Co (BDX): Total Assets
$55.33B
As of 2025-09-30
$50.73B
As of 2026-06-30
+1.5%
3-year compound annual growth
+0.5%
5-year compound annual growth
+7.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $55.33B | -3.4% | 2025-11-25, Balance as of period end |
| 2024-09-30 | $57.29B | +8.5% | 2025-11-25, Balance as of period end |
| 2023-09-30 | $52.78B | -0.3% | 2024-11-27, Balance as of period end |
| 2022-09-30 | $52.93B | -1.7% | 2023-11-21, Balance as of period end |
| 2021-09-30 | $53.87B | -0.3% | 2022-11-22, Balance as of period end |
| 2020-09-30 | $54.01B | +4.3% | 2021-11-24, Balance as of period end |
| 2019-09-30 | $51.77B | -4.0% | 2020-11-25, Balance as of period end |
| 2018-09-30 | $53.90B | +42.9% | 2020-11-25, Balance as of period end |
| 2017-09-30 | $37.73B | +47.5% | 2019-11-27, Balance as of period end |
| 2016-09-30 | $25.59B | -3.4% | 2018-11-21, Balance as of period end |
| 2015-09-30 | $26.48B | +113.8% | 2017-11-22, Balance as of period end |
| 2014-09-30 | $12.38B | +1.9% | 2016-11-23, Balance as of period end |
| 2013-09-30 | $12.15B | +6.9% | 2015-11-25, Balance as of period end |
| 2012-09-30 | $11.36B | +8.9% | 2014-11-26, Balance as of period end |
| 2011-09-30 | $10.43B | +8.1% | 2013-11-27, Balance as of period end |
| 2010-09-30 | $9.65B | +3.7% | 2012-11-21, Balance as of period end |
| 2009-09-30 | $9.30B | +17.6% | 2011-11-23, Balance as of period end |
| 2008-09-30 | $7.91B | n/a | 2010-11-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Becton Dickinson & Co (BDX) | 2025-09-30 | $55.33B | -3.4% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $43.67B | +10.9% |
| 3M Co (MMM) | 2025-12-31 | $37.73B | -5.4% |
| Stryker Corp (SYK) | 2025-12-31 | $47.84B | +11.3% |
| Medline Inc. (MDLN) | 2025-12-31 | $38.48B | +7.0% |
| Baxter International Inc (BAX) | 2025-12-31 | $20.05B | -22.2% |
| Solventum Corp (SOLV) | 2025-12-31 | $14.29B | -1.1% |
| ResMed Inc (RMD) | 2026-06-30 | $8.97B | +9.7% |
| Dexcom Inc (DXCM) | 2025-12-31 | $6.34B | -2.2% |
Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗